As part of Newswire's Media and Marketing Guided Tour program, the company earned two valuable media mentions in a Reader's Digest feature article and an interview on a New Jersey-New York metropolitan news station.
NEW YORK, August 12, 2021 (Newswire.com) - Newswire's client is a market-leading innovator and science-based manufacturer of regenerative products.
Through innovation, safety and quality, the company is expanding the science of cutting-edge human cell and tissue technologies by way of research and an extensive library of intellectual property regarding exosomes and their utility.
As a result, the company has created an innovative therapy that utilizes the anti-inflammatory and regenerative effects of bone-marrow taken from mesenchymal stem cells (MSCs).
The drug has been approved by the United States Food and Drug Administration (FDA) for use to treat COVID-19-related Acute Respiratory Distress Syndrome (ARDS), which the National Center for Biotechnology Information reports has a 45% mortality rate.
The topic of COVID-19 was at the forefront of two of its recent top-tier earned media mentions, including a feature article in Reader's Digest and an interview with a news station in the New Jersey-New York metropolitan area.
In both earned media mentions, the company's Chief Medical Officer was positioned as a thought leader and spoke about a number of topics, such as the COVID-19 vaccine and how their new product is proving to be a viable treatment in the fight against the coronavirus.
"Our client continues to do an amazing job at leveraging their knowledge and innovation in regenerative healing to help patients who are gravely ill with COVID-19-related ARDS," said Charlie Terenzio, CMO and SVP of Media and Marketing Communications at Newswire. "We were able to leverage our industry-leading solutions to secure these earned media mentions, which gave its Chief Medical Officer a platform to discuss the safety and efficacy profile of its product and also build brand awareness for the company."
For its Guided Tour customers, Newswire leverages its press release distribution services to act as an extension of its clients' teams to identify media opportunities, create compelling stories, launch targeted campaigns, and provide reports on overall performance.
Through the media and marketing communication strategy that was created based on the client's goals, Newswire's team of experts continues to help the company earn valuable media mentions, position them as a thought leader in regenerative therapies and extracellular vesicle research, and drive new and qualified leads for potential partnership opportunities.
"These opportunities are a great example of how we help our clients build brand awareness by leveraging thought leadership content to stay in front of their target audiences," Terenzio noted.
To learn more about how Newswire's integrated solutions are helping companies grow their audience, expand their reach, and implement an effective go-to-market strategy, visit Newswire.com today.
About Newswire
Newswire delivers press release and multimedia distribution software and services (SaaS) that empower the Earned Media Advantage: greater brand awareness, increased traffic, greater return on media and marketing communications spend, and the competitive edge. With over a decade of experience, Newswire continues to provide its customers with the ability to deliver the right message to the right audience at the right time through the right medium.
For more information, visit http://www.newswire.com.
Contact Information
Charlie Terenzio
CMO and SVP of Media and Marketing Communications
Newswire
Office: 813-480-3766
Email: charlie@newswire.com
Source: Newswire
Share:
